Healthcare Company Pops On Oversubscribed Private Placement

Healthcare Company Pops On Oversubscribed Private Placement

By: Dylan Sikes – AllPennyStocks.com News

Thursday, January 21, 2021

A small Calgary-based healthcare company announced today the closing of an oversubscribed $2.5 Million private placement financing as well as communications engagement for investor relations services. FluroTech Ltd. (TSX-Venture:TEST) said that in the second and final tranche of its non-brokered private placement, 15,644,844 units were sold at a price of $0.135 per unit. 

FluroTech Ltd. is a technology and marketing company. Its core business is focused on the commercialization of new technologies in the cannabis hemp industries. Its product includes CompleTest.

Traders seemed to be optimistic on the news as shares rose to a session high of $.47/share (+30.5%). This move is a continuation of the success the stock has had over the last month as well as a bullish breakout above a prior resistance level set back in September 2020.


Copyright © 2021 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Shares of Biopharma Up After News of Uplisting
Mixed Shelf Filing Gives Micro Cap Delayed Boost
Key Executive Appointment Sends Small Cap Higher
Most Popular
FREE Newsletter
AllPennyStocks.com Favorites


Back to Top